Finance

Lists
LALPATHLAB:NSE
Dr. Lal PathLabs Ltd
₹1 929,90
+1,63%
(+31,00) 1D
9 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for LALPATHLAB...
Open
₹1 898,90
High
₹1 942,80
Low
₹1 882,80
Mkt. cap
159,70 mjd
Avg. vol.
310,78 k
Volume
167,90 k
Dividend
0,83%
Quarterly dividend
₹4,00
Ex-dividend date
25 Jun. 2026
P/E ratio
59,57
52-wk high
₹2 038,60
52-wk low
₹1 272,60
EPS
₹32,40
Shares outstanding
83,34 m
No. of employees
5 k
Open
₹1 898,90
High
₹1 942,80
Low
₹1 882,80
Mkt. cap
159,70 mjd
Avg. vol.
310,78 k
Volume
167,90 k
Dividend
0,83%
Quarterly dividend
₹4,00
Ex-dividend date
25 Jun. 2026
P/E ratio
59,57
52-wk high
₹2 038,60
52-wk low
₹1 272,60
EPS
₹32,40
Shares outstanding
83,34 m
No. of employees
5 k
News stories
From web sources and news partners
Profile
Dr Lal PathLabs Limited is an Indian service provider of diagnostic and related healthcare tests. Based in New Delhi, the company offers tests on blood, urine and other human body viscera. Wikipedia
About Dr. Lal PathLabs Ltd
CEO-
Employees5,21 k
Founded1949
Headquarters-
SectorHealth care provider
Last report
24 Jul. 2026
Fiscal period
Q1 2027
₹10,13 / ₹10,31
-1,78%miss
Revenue / Est. (INR)
7,98 mjd / 7,58 mjd
+5,22%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
7,31 mjd
6,60 mjd
7,03 mjd
7,98 mjd
Cost of goods sold
2,74 mjd
2,63 mjd
3,21 mjd
2,84 mjd
Cost of revenue
2,74 mjd
2,63 mjd
3,21 mjd
2,84 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,06 mjd
958,00 m
2,32 mjd
1,16 mjd
Operating expense
2,73 mjd
2,59 mjd
2,35 mjd
3,10 mjd
Total operating expenses
5,47 mjd
5,23 mjd
5,55 mjd
5,95 mjd
Operating income
1,84 mjd
1,37 mjd
1,47 mjd
2,03 mjd
Other non operating income
248,00 m
244,00 m
-752,10 m
319,00 m
EBT including unusual items
2,04 mjd
1,24 mjd
1,60 mjd
2,29 mjd
EBT excluding unusual items
2,04 mjd
1,54 mjd
1,33 mjd
2,29 mjd
Income tax expense
514,00 m
329,00 m
279,31 m
582,00 m
Effective tax rate
25,25%
26,47%
17,45%
25,45%
Other operating expenses
1,26 mjd
1,22 mjd
-425,41 m
1,50 mjd
Net income
1,51 mjd
905,00 m
1,31 mjd
1,70 mjd
Net profit margin
20,61%
13,72%
18,68%
21,25%
Earnings per share
9,00
6,73
8,44
10,13
Interest and investment income
-
-
670,12 m
-
Interest expense
-48,00 m
-72,00 m
-61,00 m
-63,00 m
Net interest expenses
-48,00 m
-72,00 m
609,12 m
-63,00 m
Depreciation and amortization charges
405,00 m
421,00 m
446,03 m
444,00 m
EBITDA
2,21 mjd
1,62 mjd
1,76 mjd
2,32 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme